United States - English
Call us toll free on 1-518-730-1569
Home / Medical Devices / COVID-19 Impact on Global Nuclear Medicine Radioisotopes Market Insights, Forecast to 2026

COVID-19 Impact on Global Nuclear Medicine Radioisotopes Market Insights, Forecast to 2026

Published: Jun 2020 Total Pages: 111 | Published By: QYResearch Group

Nuclear medicine has a huge potential in treating cancer and cardiac diseases. Growth of medical imaging is an opportunity for the growth of the global nuclear medicine radioisotope market, as both markets are correlated. Radiopharmaceuticals are approved by the Food and Drug Administration (FDA) as either drugs or biologics.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Nuclear Medicine Radioisotopes market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Nuclear Medicine Radioisotopes industry.

Based on our recent survey, we have several different scenarios about the Nuclear Medicine Radioisotopes YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 3440.3 million in 2019. The market size of Nuclear Medicine Radioisotopes will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nuclear Medicine Radioisotopes market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nuclear Medicine Radioisotopes market in terms of both revenue and volume.

Players, stakeholders, and other participants in the global Nuclear Medicine Radioisotopes market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.

Production and Pricing Analyses

Readers are provided with deeper production analysis, import and export analysis, and pricing analysis for the global Nuclear Medicine Radioisotopes market. As part of production analysis, the report offers accurate statistics and figures for production capacity, production volume by region, and global production and production by each type segment for the period 2015-2026.

In the pricing analysis section of the report, readers are provided with validated statistics and figures for price by manufacturer and price by region for the period 2015-2020 and price by each type segment for the period 2015-2026. The import and export analysis for the global Nuclear Medicine Radioisotopes market has been provided based on region.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Nuclear Medicine Radioisotopes market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of volume for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Nuclear Medicine Radioisotopes market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nuclear Medicine Radioisotopes market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nuclear Medicine Radioisotopes market.

The following manufacturers are covered in this report:

Agfa-Gevaert Group

Braco

Cardiarc

Cardinal Health

CMR Naviscan (Gamma Medica Inc.)

Curium

Digirad

GE Healthcare

Nordion (Canada)

NTP Radioisotopes SOC

Positron

Segami

Siemens Healthcare

Nuclear Medicine Radioisotopes Breakdown Data by Type

Thallium-201 (Tl-201)

Iodine (I-123)

Fluorine-18

Rubidium-82 (Rb-82)

Other

Nuclear Medicine Radioisotopes Breakdown Data by Application

Tumor

Heart Disease

Lymphoma

Thyroid Gland

Other

Choose License Type
Payments and Security
Payments and Security
Have a Question


If you have a general question try our FAQ page.

Why Order from Us

Quality

Working with the worlds leading market research companies.

Variety

Over 100,000 research reports across 170 industries.

Value

Simple license based pricing by individual report.

Reliability

Trusted by thousands for accurate and transparent reports.

Frequently Asked Licensing Questions

Which format are the reports delivered in?

Unless otherwise specified all reports are sent electronically in either .PDF or .DOC file format.

What kind of license is typically available for electronic report formats?

Single User License: It provides product access only to the consumer of the ordered product.

Multi User License: It allows maximum up to 10 peoples within your company to share the ordered product.

Global License: It permits the product to be shared by all employees of your firm irrespective of their geographical areas.

Fore more information on report format options and licensing please visit our FAQ's page.

What our clients have to say